UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A side-by-side look at Sp 500 Equity and Multi Asset Retirement allocations, examining growth potential, risk, and diversification for retirement planning.
27,235 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
As AI investment expands across big-cap tech and startups, ACM Research and Ouster emerge as practical additions to s...
AMD posts a sharp rise in free cash flow as data center demand surges, while Intel bankrolls a costly foundry rebuild...
SpaceX has filed its S-1 ahead of a long-anticipated IPO, revealing a diversified, revenue-rich business anchored by ...
SpaceX's blockbuster IPO delivered record cash and a sky-high valuation, but a $17 billion mispricing—the billion mis...
A reported plan for Apple to source memory chips from a Chinese supplier could upend Micron’s mobile business and cha...
A decade-long fundraising effort across 16 states and 35 coastal organizations has helped revive the American oysterc...
Ondas Holdings rides a Mistral merger to prime DoD contractor status, unlocking access to more than $1 billion in def...
Micron Technology rides a surge in AI memory demand, delivering stronger margins and robust cash flow. As the company...
Qualcomm has vaulted from March lows as auto and IoT growth accelerates. Yet market skeptics linger, with hyperscaler...
Elon Musk says ASML has cemented its status as Europe’s top tech company, a claim that reverberates through chip equi...
Tesla posted solid Q1 2026 results but CEO Elon Musk tempered enthusiasm for Optimus and the Robotaxi, signaling grad...